Halozyme Therapeutics, Inc. (HALO) - Stock Prices, Stock Peers & Analysis

Home
HALO

Company Name	Halozyme Therapeutics, Inc.
Symbol	HALO
Currency	USD
Price	54.8
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	6,972,039,600
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	33.15 - 65.53
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Website	https://www.halozyme.com

An error occurred while fetching data.

About Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies